Center for International Blood and Marrow Transplant Research
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Participants who fulfill the following criteria will be eligible for inclusion in this Registry Study.
Participant must be treated with eli-cel in the post marketing setting at a center in the United States (US) that participates in the Registry Study.
Participant must have provided an informed consent and/or assent to participate in Center for International Blood and Marrow Transplant Research (CIBMTR) registry.
Participant must have provided an informed consent and/or assent to participate in the Registry Study.
Participant must receive follow up care by a US-based physician with the ability to submit REG-502 data.
